Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Cipher Pharmaceuticals Inc
SWB:PHE
Cipher Pharmaceuticals Inc
SWB:PHE
Price:
8.65
EUR
-22.07%
Market Closed
Market Cap:
€47.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently viewed
Price
Wall St Price Targets
PHE Price Forecast
Based on 5 analysts
Based on 5 analysts
+47% Upside
from
€8.65
today
Cipher Pharmaceuticals Inc (PHE)’s 12-month stock price forecast through November 2027 has a consensus target of €12.67, implying 47% upside. The forecast is based on price targets from 5 Wall Street analysts.
PHE Analyst Rating
No ratings yet
No ratings yet
Cipher Pharmaceuticals Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PHE's stock price target?
Price Target
12.67
EUR
12.67
EUR
According to Wall Street analysts, the average 1-year price target for PHE is 12.67 EUR with a low forecast of 10.8 EUR and a high forecast of 14.07 EUR.
What is the Revenue forecast for Cipher Pharmaceuticals Inc?
Projected CAGR
7%
7%
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 3 years is 7%.
What is the Gross Profit forecast for Cipher Pharmaceuticals Inc?
Projected CAGR
11%
11%
The compound annual growth rate for Gross Profit over the next 3 years is 11%.
What is the Operating Income forecast for Cipher Pharmaceuticals Inc?
Projected CAGR
31%
31%
Over the last 13 years, the compound annual growth rate for Operating Income has been 16%. The projected CAGR for the next 1 year is 31%.
What is the Pre-Tax Income forecast for Cipher Pharmaceuticals Inc?
Projected CAGR
29%
29%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 16%. The projected CAGR for the next 3 years is 29%.
What is the Net Income forecast for Cipher Pharmaceuticals Inc?
Projected CAGR
-4%
-4%
Over the last 13 years, the compound annual growth rate for Net Income has been 20%. The projected CAGR for the next 3 years is -4%.
